Skip to main content
Kathryn Lurain, MD, Hematology, Columbus, OH

Kathryn Lurain MD MPH

Hematologic Oncology


Associate Professor

Join to view full profile
  • 2121 Kenny RdColumbus, OH 43210

  • Phone+1 614-293-3196

  • Fax+1 614-293-4812

Dr. Lurain is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Kathryn Lurain is an hematologic oncologist at the Ohio State University. She received her medical degree from the University of Virginia School of Medicine and did her internal medicine residency training at the University of Chicago. She did her fellowship training in hematology and oncology at the National Cancer Institute. She specializes in virus-associated lymphomas.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2018
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 2012 - 2015
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 2012

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2025 - 2027
  • IL State Medical License
    IL State Medical License 2015 - 2026
  • DC State Medical License
    DC State Medical License 2015 - 2016
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Discovery of Kaposi’s Sarcoma Herpesvirus-Encoded Circular RNAs and a Human Antiviral Circular RNA  
    Ramya Ramaswami, Kathryn Lurain, Thomas S Uldrick, Proceedings of the National Academy of Sciences

Lectures

  • Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R2) in Primary Effusion Lymphoma in Patients with or without HIV 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Checkpoint Immunotherapy Is Safe and Effective for HIV-Positive People with Cancer
    Checkpoint Immunotherapy Is Safe and Effective for HIV-Positive People with CancerJune 22nd, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: